"And the stars are projectors, yeah, projecting our lives down to this planet Earth." - Modest Mouse
Wired reports that the DEA has approved clinical trials testing the efficacy of MDMA in treating post-traumatic stress disorder. 12 patients will undergo therapy in the study funded by the Multidisciplinary Association for Psychedelic Studies.
Study volunteers will receive two 125 milligram doses of pure 3,4-methylenedioxymethamphetamine (MDMA) synthesized by a chemist at Purdue University. A control group will receive a placebo. Patients will take the medication on two separate occasions spaced three to five weeks apart, combined with talk therapy sessions.In an age of drug stores & Drug Wars it's nice to see the DEA opening up a bit to the therapeutic potential of empathogenic & psychedelic compounds. The human mind is vast and seemingly boundless and we should use any tools we find to peer into its depths.
Therapists as well as casual users believe Ecstasy can help people suffering from post-traumatic stress and other psychological problems because the drug creates feelings of euphoria, warmth and empathy. Most say that combining the drug with therapy is key to helping patients learn to incorporate what they experience on the drug into their everyday lives.
Comments: Post a Comment